Neon Therapeutics, Inc. (NTGN): Price and Financial Metrics

Neon Therapeutics, Inc. (NTGN)

Today's Latest Price: $1.66 USD

0.10 (-5.68%)

Updated Jan 24 5:41pm

Add NTGN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

NTGN Daily Price Range
NTGN 52-Week Price Range

NTGN Stock Price Chart More Charts

NTGN Price/Volume Stats

Current price $1.66 52-week high $7.51
Prev. close $1.76 52-week low $0.88
Day low $1.62 Volume 376,452
Day high $1.78 Avg. volume 679,175
50-day MA $1.29 Dividend yield N/A
200-day MA $3.12 Market Cap 47.04M

Neon Therapeutics, Inc. (NTGN) Company Bio

Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial in combination with nivolumab for the treatment of metastatic melanoma, non-small cell lung cancer, and bladder cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of estrogen-receptor-positive breast cancer. The company was founded in 2013 and is based in Cambridge, Massachusetts.

NTGN Latest News Stream

Event/Time News Detail
Loading, please wait...

NTGN Latest Social Stream

Loading social stream, please wait...

View Full NTGN Social Stream

NTGN Price Returns

1-mo 29.69%
3-mo -20.19%
6-mo -42.56%
1-year -65.56%
3-year N/A
5-year N/A
YTD 40.68%
2019 -76.54%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5619 seconds.